Cipla Ltd

  • BSE Code : 500087
  • NSE Symbol : CIPLA
  • ISIN : INE059A01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,314.70 -9.60(-0.72%)

Open Price ()

1,324.30

Prev. Close ()

1,324.30

Volume (No’s)

1,346,347

Market Cap ()

106,198.93

Low Price ()

1,301.00

High Price ()

1,327.50

 

Board Meetings

Start Date End Date Purpose
23-Dec-2025 23-Jan-2026 Quarterly Results Please find attached financial results for quarter and nine months ended 31st December 2025 The Board meeting of the Company which commenced today at 11:00 a.m. (IST) and is still in progress. Cipla Limited has informed the Exchange that the Board has approved the re-appointment of Mr P R Ramesh as Independent Director of the Company for a second term of five consecutive years, subject to approval of the shareholders. (As per BSE Announcement dated on: 23.01.2026)
24-Sep-2025 30-Oct-2025 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 Outcome of Board meeting dated 30th October, 2025 (As per BSE Announcement dated on: 30.10.2025)
01-Jul-2025 25-Jul-2025 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Tuesday 1st July 2025 till Sunday 27th July 2025 (both days inclusive) for the purpose of financial results. Please find attached financial results for the quarter ended 30th June 2025 (As Per BSE Announcement Dated on: 25.07.2025)
07-Apr-2025 13-May-2025 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve 1. the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2025. 2. Recommend final dividend for the year ended 31st March 2025 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Tuesday 1st April 2025 till Thursday 15th May 2025 (both days inclusive) for the purpose of financial results. Please find enclosed the result dated 13th May 2025 The Board of Directors of the Company also recommended a final dividend of INR 13/- per equity share for the financial year ended 31 st March, 2025 and a special dividend of INR 3/- per equity share on the occasion of completing 90 years of the Company, taking the total dividend to INR 16/- per equity share (face value INR 2 each). The dividend, upon approval by the shareholders, will be paid to shareholders within 30 days from the date of the Annual General Meeting. The record date for the purpose of payment of final dividend, if declared, shall be 27 th June, 2025. Please find enclosed intimation Please find enclosed intimation on ESOP ESAR grant and AGM date (As Per BSE Announcement Dated on: 13.05.2025)
06-Jan-2025 28-Jan-2025 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 31st December 2024. Unaudited Financial Results (standalone and consolidated) for the quarter and nine months ended 31st December, 2024. Outcome of Board Meeting dated 28th January, 2025 (As Per BSE Announcement dated on 28.01.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew